Chester County News and Community Website
PHOENIXVILLE, PA — PleoPharma, Inc. has announced a significant intellectual property milestone with the issuance of its third U.S. patent, aimed at addressing sleep disturbances linked to cannabis withdrawal syndrome …
PleoPharma Secures Patent for Treating Sleep Disturbances in Cannabis Withdrawal Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. patent application number …
Windtree Therapeutics Secures Patent for Istaroxime IV Formulation in Acute Heart Failure Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has been granted a U.S. patent for the use of its leading compound, buntanetap, in the treatment and prevention of acute brain and …
Annovis Bio Secures U.S. Patent for Neuroprotective Drug Buntanetap Read More
BRISTOL, PA — Sojo Industries has been awarded a U.S. patent for its groundbreaking Mobile Automated Modular Variety and Multi-pack Production Line and System Solution, known as Sojo Flight™. This …
Sojo Industries Secures U.S. Patent for Revolutionary Sojo Flight System Read More WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced the issuance of a new patent for istaroxime in Hong Kong, titled “Istaroxime-containing intravenous formulation for the treatment of heart …
Windtree Therapeutics Secures Hong Kong Patent for Istaroxime in Heart Failure Treatment Read More
PHILADELPHIA, PA — EpiVario, Inc. has announced that the United States Patent and Trademark Office has granted them US Patent No. 12,077,527, while the Japan Patent Office has issued a …
EpiVario Secures Key Patents for Innovative Addiction Treatment Read More
JENKINTOWN, PA — SFA Therapeutics, Inc., a biotech firm specializing in autoimmune diseases and hepatocellular carcinoma, announced a significant expansion of its intellectual property this week. The company secured a …
SFA Therapeutics Strengthens Patent Portfolio for Key Drug Candidates Read More WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced the completion of national phase filings for its istaroxime patent applications across key global markets, including the United States, Germany, …
Windtree Therapeutics Secures Global Patent Filings for Istaroxime Read More
RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) has fortified its intellectual property holdings with the United States Patent and Trademark Office’s issuance of a new patent for ZTALMY® (ganaxolone) oral …
Marinus Pharmaceuticals Expands Intellectual Property Portfolio with New ZTALMY® Patent Read More PHOENIXVILLE, PA — PleoPharma, Inc. has announced the issuance of two critical U.S. patents that bolster its efforts to treat cannabis withdrawal syndrome (CWS). These patents, U.S. Patent 11,197,846 and U.S. …
PleoPharma Secures Key Patents for Cannabis Withdrawal Treatment Read More